Spermiogenesis in Sperm Genetic Integrity

2013 ◽  
pp. 97-114
Author(s):  
Marie-Chantal Grégoire ◽  
Frédéric Leduc ◽  
Guylain Boissonneault
Keyword(s):  
2014 ◽  
Vol 28 (2) ◽  
pp. 29-33 ◽  
Author(s):  
I.O. Daniel ◽  
O.W. Adabale ◽  
K.A. Adeboye ◽  
E.S. Aladele ◽  
O.T. Oduoye ◽  
...  

Author(s):  
В.В. Лапаева

Правовая политика России в сфере создания и применения генетических технологий в медицине не обеспечивает в должной мере баланс между системой прав человека, гарантирующих защиту его достоинства и охрану здоровья, и свободой научного творчества. Несогласованность этих прав человека проявляется в том, что при отсутствии запретов на исследования с применением технологий наследуемого редактирования генома человека законодательство лишает патентоспособности любые технологии по модификации генетической целостности клеток зародышевой линии человека. Последовательный правовой подход предполагает введение ограничений на возможность геномного редактирования зародышевой линии и запрета на патентование способов такого редактирования, не выходящего за рамки заданных ограничений. При разработке такого похода целесообразно учесть опыт Великобритании. The Russian legal policy in the field of the medicine genetic technologies creation and application does not provide a proper balance between the system of human rights that guarantee the protection of its dignity and health, and the freedom of scientific creativity. The non-coordination of these human rights is manifested in the fact that in the absence of prohibitions on research using technologies of human genome inherited editing, the law deprives patentability of any technology for modifying the genetic integrity of human germline cells. A consistent legal approach involves the restrictions on the possibility of the germ line genomic editing and the prohibition of patenting the methods of such editing, which does not go beyond the given restrictions. It is advisable to take into account the experience of Great Britain.


2018 ◽  
Vol 68 (5) ◽  
pp. 545-553 ◽  
Author(s):  
Allan Mata-Quirós ◽  
Adriana Arciniegas-Leal ◽  
Wilbert Phillips-Mora ◽  
Lyndel W. Meinhardt ◽  
Lambert Motilal ◽  
...  

2015 ◽  
Vol 51 (5) ◽  
pp. 505-513 ◽  
Author(s):  
Zhibo Zhang ◽  
Gry Skjeseth ◽  
Abdelhameed Elameen ◽  
Sissel Haugslien ◽  
Astrid Sivertsen ◽  
...  

Author(s):  
Marie-Chantal Grégoire ◽  
Frédéric Leduc ◽  
Guylain Boissonneault
Keyword(s):  

2015 ◽  
Vol 9 (3) ◽  
pp. 299-324 ◽  
Author(s):  
Oleg E. Kosterin ◽  
Vladimir I. Solovyev ◽  
Yuri Ilinsky

2017 ◽  
Vol 7 (7) ◽  
pp. 2065-2080 ◽  
Author(s):  
Kanokwan Srirattana ◽  
Justin C St. John

Abstract The mixing of mitochondrial DNA (mtDNA) from the donor cell and the recipient oocyte in embryos and offspring derived from somatic cell nuclear transfer (SCNT) compromises genetic integrity and affects embryo development. We set out to generate SCNT embryos that inherited their mtDNA from the recipient oocyte only, as is the case following natural conception. While SCNT blastocysts produced from Holstein (Bos taurus) fibroblasts were depleted of their mtDNA, and oocytes derived from Angus (Bos taurus) cattle possessed oocyte mtDNA only, the coexistence of donor cell and oocyte mtDNA resulted in blastocysts derived from nondepleted cells. Moreover, the use of the reprogramming agent, Trichostatin A (TSA), further improved the development of embryos derived from depleted cells. RNA-seq analysis highlighted 35 differentially expressed genes from the comparison between blastocysts generated from nondepleted cells and blastocysts from depleted cells, both in the presence of TSA. The only differences between these two sets of embryos were the presence of donor cell mtDNA, and a significantly higher mtDNA copy number for embryos derived from nondepleted cells. Furthermore, the use of TSA on embryos derived from depleted cells positively modulated the expression of CLDN8, TMEM38A, and FREM1, which affect embryonic development. In conclusion, SCNT embryos produced by mtDNA depleted donor cells have the same potential to develop to the blastocyst stage without the presumed damaging effect resulting from the mixture of donor and recipient mtDNA.


2002 ◽  
Vol 11 (6) ◽  
pp. 1017-1027 ◽  
Author(s):  
Claudia C. Englbrecht ◽  
Ulrich Schliewen ◽  
Diethard Tautz

2011 ◽  
Vol 32 (1) ◽  
pp. 106-111 ◽  
Author(s):  
Joost O. Linschooten ◽  
Julian Laubenthal ◽  
Eduardo Cemeli ◽  
Adolf Baumgartner ◽  
Diana Anderson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document